Cyient Limited - 532175 - Closure of Trading Window
Closure of Trading window31-03-2020
Cyient Limited - 532175 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
press releaseCyient Limited - 532175 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Cyient Ltd has submitted to BSE a copy of Clarification is enclosed.Cyient Limited - 532175 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for FMR LLC and FIL LtdCyient Limited - 532175 - Clarification sought from Cyient Ltd
The Exchange has sought clarification from Cyient Ltd on 25th March, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaitedCyient Ltd - 532175 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend
The date payment for the 2nd interim dividend is 30 March 2020.Cyient Ltd - 532175 - Record Date - 2Nd Interim Dividend
24 March 2020 is fixed as the record date for the 2nd interim dividend purpose and the dividend will be paid on 30 March 2020.Cyient Limited - 532175 - Corporate Action-Board approves Dividend
We would like to inform you that at the Board Meeting held today, the Directors have declared a 2nd Interim dividend of Rs. 9/- per equity share (i.e. 180 %) on par value of Rs. 5/- per share for the financial year 2019-20.Cyient Limited - 532175 - Declaration Of 2Nd Interim Dividend For FY 2019-20 And Intimation Of Record Date
We would like to inform you that at the Board Meeting held today, the Directors have declared a 2nd Interim dividend of Rs. 9/- per equity share (i.e. 180 %) on par value of Rs. 5/- per share for the financial year 2019-20.Cyient Limited - 532175 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon Life India Asset Management Ltd